H-Index & Metrics Top Publications

H-Index & Metrics

Discipline name H-index Citations Publications World Ranking National Ranking
Medicine H-index 223 Citations 199,995 1,313 World Ranking 27 National Ranking 20

Research.com Recognitions

Awards & Achievements

2012 - Libin/AHFMR Prize in Cardiovascular Research

2004 - Member of the National Academy of Medicine (NAM)

Member of the Association of American Physicians


What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Myocardial infarction
  • Surgery

His primary scientific interests are in Internal medicine, Myocardial infarction, Cardiology, Surgery and Angioplasty. Percutaneous coronary intervention, Randomized controlled trial, Stroke, Aspirin and Unstable angina are the subjects of his Internal medicine studies. His Myocardial infarction research integrates issues from Coronary artery disease and Anesthesia.

His study brings together the fields of Mortality rate and Cardiology. The Surgery study combines topics in areas such as Gastroenterology, Placebo and Tissue plasminogen activator. In his study, Pathology is strongly linked to Restenosis, which falls under the umbrella field of Angioplasty.

His most cited work include:

  • An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. (3240 citations)
  • Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. (2731 citations)
  • Clopidogrel and Aspirin versus Aspirin Alone for the Prevention of Atherothrombotic Events (2298 citations)

What are the main themes of his work throughout his whole career to date?

Eric J. Topol mainly focuses on Internal medicine, Cardiology, Myocardial infarction, Surgery and Angioplasty. Internal medicine is a component of his Percutaneous coronary intervention, Revascularization, Coronary artery disease, Abciximab and Unstable angina studies. His Cardiology research includes elements of Restenosis and Percutaneous.

Eric J. Topol focuses mostly in the field of Myocardial infarction, narrowing it down to matters related to Randomized controlled trial and, in some cases, Clinical trial. Eric J. Topol frequently studies issues relating to Placebo and Surgery. His Angioplasty research includes elements of Artery, Bypass surgery, Balloon and Atherectomy.

He most often published in these fields:

  • Internal medicine (67.18%)
  • Cardiology (56.88%)
  • Myocardial infarction (48.18%)

What were the highlights of his more recent work (between 2011-2021)?

  • Internal medicine (67.18%)
  • MEDLINE (3.45%)
  • Health care (3.26%)

In recent papers he was focusing on the following fields of study:

Eric J. Topol mainly investigates Internal medicine, MEDLINE, Health care, Genetics and Cardiology. His Surgery research extends to Internal medicine, which is thematically connected. Eric J. Topol regularly links together related areas like Bioinformatics in his MEDLINE studies.

The Genetics study which covers Disease that intersects with Clinical psychology. His Cardiology research is mostly focused on the topic Myocardial infarction. Myocardial infarction is closely attributed to Pathology in his research.

Between 2011 and 2021, his most popular works were:

  • High-performance medicine: the convergence of human and artificial intelligence (972 citations)
  • Prevalence of Asymptomatic SARS-CoV-2 Infection. (904 citations)
  • The personal and clinical utility of polygenic risk scores. (434 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Myocardial infarction
  • Surgery

Health care, MEDLINE, Personalized medicine, Genetic testing and Internal medicine are his primary areas of study. His Health care study also includes fields such as

  • Medical record and Randomized controlled trial most often made with reference to Medical emergency,
  • Disease management which connect with Connected health, Glucose meter, Intervention, Receipt and Health management system. He has included themes like Telemedicine, Bioinformatics and Medical education in his MEDLINE study.

His research in Personalized medicine intersects with topics in Test and Genome-wide association study. His work deals with themes such as CYP2C19 and Cardiology, which intersect with Internal medicine. His Clopidogrel research entails a greater understanding of Myocardial infarction.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Top Publications

An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction.

Maarten Simoons;Eric Topol;Robert Califf;Frans van de Werf.
The New England Journal of Medicine (1993)

5422 Citations

Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial.

Steven R. Steinhubl;Peter B. Berger;J. Tift Mann;Edward T. A. Fry.
JAMA (2002)

3583 Citations

Clopidogrel and Aspirin versus Aspirin Alone for the Prevention of Atherothrombotic Events

Deepak L. Bhatt;Keith A.A. Fox;Werner Hacke;Peter B. Berger.
The New England Journal of Medicine (2006)

3501 Citations

Risk of cardiovascular events associated with selective COX-2 inhibitors.

D Mukherjee;S.E Nissen;E.J Topol.
JAMA (2001)

2388 Citations

Prevalence of Conventional Risk Factors in Patients With Coronary Heart Disease

Umesh N. Khot;Monica B. Khot;Christopher T. Bajzer;Shelly K. Sapp.
JAMA (2003)

1910 Citations

Effect of Antihypertensive Agents on Cardiovascular Events in Patients With Coronary Disease and Normal Blood Pressure The CAMELOT Study: A Randomized Controlled Trial

Steven E. Nissen;E. Murat Tuzcu;Peter Libby;Peter Libby;Paul D. Thompson.
JAMA (2004)

1709 Citations

Our Preoccupation With Coronary Luminology The Dissociation Between Clinical and Angiographic Findings in Ischemic Heart Disease

Eric J. Topol;Steven E. Nissen.
Circulation (1995)

1571 Citations

Textbook of Cardiovascular Medicine

Eric J. Topol.

1535 Citations

Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy.

Arman T Askari;Samuel Unzek;Zoran B Popovic;Corey K Goldman.
The Lancet (2003)

1525 Citations

High-performance medicine: the convergence of human and artificial intelligence

Eric J. Topol.
Nature Medicine (2019)

1521 Citations

Profile was last updated on December 6th, 2021.
Research.com Ranking is based on data retrieved from the Microsoft Academic Graph (MAG).
The ranking h-index is inferred from publications deemed to belong to the considered discipline.

If you think any of the details on this page are incorrect, let us know.

Contact us

Top Scientists Citing Eric J. Topol

Deepak L. Bhatt

Deepak L. Bhatt

Brigham and Women's Hospital

Publications: 451

Roxana Mehran

Roxana Mehran

Icahn School of Medicine at Mount Sinai

Publications: 418

Gregg W. Stone

Gregg W. Stone

Columbia University Medical Center

Publications: 385

Patrick W. Serruys

Patrick W. Serruys

National University of Ireland, Galway

Publications: 348

Harvey D. White

Harvey D. White

Auckland City Hospital

Publications: 341

Christopher P. Cannon

Christopher P. Cannon

Brigham and Women's Hospital

Publications: 337

Eugene Braunwald

Eugene Braunwald

Harvard Medical School

Publications: 331

David R. Holmes

David R. Holmes

Mayo Clinic

Publications: 328

Robert M. Califf

Robert M. Califf

Duke University

Publications: 327

E. Magnus Ohman

E. Magnus Ohman

Duke University

Publications: 304

Adnan Kastrati

Adnan Kastrati

Technical University of Munich

Publications: 285

C. Michael Gibson

C. Michael Gibson

Beth Israel Deaconess Medical Center

Publications: 269

Robert A. Harrington

Robert A. Harrington

Stanford University

Publications: 265

Dominick J. Angiolillo

Dominick J. Angiolillo

University of Florida

Publications: 257

Christopher B. Granger

Christopher B. Granger

Duke University

Publications: 247

Something went wrong. Please try again later.